Neurogene
NGNE
NGNE
36 hedge funds and large institutions have $53.7M invested in Neurogene in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.19% less ownership
Funds ownership: 3.54% → 3.35% (-0.19%)
Holders
36
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$2.84M | |
| 2 | +$1.17M | |
| 3 | +$1.15M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$1.06M |
| 5 |
Renaissance Technologies
New York
|
+$812K |
Top Sellers
| 1 | -$344K | |
| 2 | -$277K | |
| 3 | -$174K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$114K |
| 5 |
SIM
Spark Investment Management
New York
|
-$109K |